当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い
。オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル と 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得
Donald Palmer
Tertiary disease prevention for dementia is based on improving the patient's quality of life. The development of behavioural and psychological symptoms of dementia (BPSD), such as anxiety and depression, hampers the quality of life of people with dementia (PwD) and their caregivers. In coping with these symptoms, non-pharmacological treatments have proven useful. However, although most PwD show BPSD, their manifestation varies widely among patients (in frequency, intensity and type).
To test these treatments, instruments for evaluating behavioural symptoms of dementia, such as NPI-NH and CMAI, are traditionally used. In dementia studies, we propose the use of activity trackers as a supplement to control behavioural symptoms. We explain a nine-week cognitive enhancement therapy carried out with the aid of a social robot, in which the ten participants wore an activity tracker to demonstrate this strategy.